These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 9886713)

  • 1. Hyperuricaemia and congestive heart failure: causation or association?
    Gottlieb S
    Eur Heart J; 1998 Dec; 19(12):1746-7. PubMed ID: 9886713
    [No Abstract]   [Full Text] [Related]  

  • 2. Uric acid, xanthine oxidase and heart failure: unresolved issues.
    Verdejo H; Alcaino H; Greig D; Garcia L; Pizarro M; Chiong M; Castro P; Lavandero S
    Eur J Heart Fail; 2008 Dec; 10(12):1271-2. PubMed ID: 19010082
    [No Abstract]   [Full Text] [Related]  

  • 3. Uric acid in CHF: marker or player in a metabolic disease?
    Doehner W; von Haehling S; Anker SD
    Int J Cardiol; 2007 Feb; 115(2):156-8. PubMed ID: 16844250
    [No Abstract]   [Full Text] [Related]  

  • 4. Uric acid predicts clinical outcomes in heart failure: insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology.
    Hare JM; Johnson RJ
    Circulation; 2003 Apr; 107(15):1951-3. PubMed ID: 12707249
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes in xanthine oxidase activity in patients with circulatory failure].
    Bakhtiiarov ZA
    Ter Arkh; 1989; 61(5):68-9. PubMed ID: 2781495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uric acid in chronic heart failure: a marker of chronic inflammation.
    Leyva F; Anker SD; Godsland IF; Teixeira M; Hellewell PG; Kox WJ; Poole-Wilson PA; Coats AJ
    Eur Heart J; 1998 Dec; 19(12):1814-22. PubMed ID: 9886724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of uric acid in heart failure].
    Alcaíno H; Greig D; Castro P; Verdejo H; Mellado R; García L; Díaz-Araya G; Quiroga C; Chiong M; Lavandero S
    Rev Med Chil; 2011 Apr; 139(4):505-15. PubMed ID: 21879191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uric acid in cachectic and noncachectic patients with chronic heart failure: relationship to leg vascular resistance.
    Doehner W; Rauchhaus M; Florea VG; Sharma R; Bolger AP; Davos CH; Coats AJ; Anker SD
    Am Heart J; 2001 May; 141(5):792-9. PubMed ID: 11320368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uric acid and xanthine oxidase in heart failure - Emerging data and therapeutic implications.
    Doehner W; Jankowska EA; Springer J; Lainscak M; Anker SD
    Int J Cardiol; 2016 Jun; 213():15-9. PubMed ID: 26318388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ongoing search for a stratified medicine approach in heart failure.
    Tang WH
    J Am Coll Cardiol; 2008 Jun; 51(24):2310-2. PubMed ID: 18549914
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of xanthine oxidase inhibition upon ejection fraction in heart failure patients: La Plata Study.
    Cingolani HE; Plastino JA; Escudero EM; Mangal B; Brown J; Pérez NG
    J Card Fail; 2006 Sep; 12(7):491-8. PubMed ID: 16952781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The paradoxical relationship between serum uric acid and cardiovascular disease.
    Lippi G; Montagnana M; Franchini M; Favaloro EJ; Targher G
    Clin Chim Acta; 2008 Jun; 392(1-2):1-7. PubMed ID: 18348869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xanthine oxidase inhibitors: an emerging class of drugs for heart failure.
    Kittleson MM; Hare JM
    Eur Heart J; 2005 Aug; 26(15):1458-60. PubMed ID: 15917281
    [No Abstract]   [Full Text] [Related]  

  • 14. Uric acid--a marker for systemic inflammatory response in patients with congestive heart failure?
    Olexa P; Olexová M; Gonsorcík J; Tkác I; Kisel'ová J; Olejníková M
    Wien Klin Wochenschr; 2002 Mar; 114(5-6):211-5. PubMed ID: 12238311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of procyanidins from grape seeds reduces serum uric acid levels and decreases hepatic xanthine dehydrogenase/oxidase activities in oxonate-treated mice.
    Wang Y; Zhu JX; Kong LD; Yang C; Cheng CH; Zhang X
    Basic Clin Pharmacol Toxicol; 2004 May; 94(5):232-7. PubMed ID: 15125693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is uric acid itself a player or a bystander in the pathophysiology of chronic heart failure?
    Duan X; Ling F
    Med Hypotheses; 2008; 70(3):578-81. PubMed ID: 17689199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging.
    Anker SD; Doehner W; Rauchhaus M; Sharma R; Francis D; Knosalla C; Davos CH; Cicoira M; Shamim W; Kemp M; Segal R; Osterziel KJ; Leyva F; Hetzer R; Ponikowski P; Coats AJ
    Circulation; 2003 Apr; 107(15):1991-7. PubMed ID: 12707250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uric acid and cardiovascular risk.
    Oh J; Won HY; Kang SM
    N Engl J Med; 2009 Jan; 360(5):539-40; author reply 540-1. PubMed ID: 19186314
    [No Abstract]   [Full Text] [Related]  

  • 19. [Uric acid as a marker of pathophysiological mechanisms in patients with cardiovascular disease].
    Calberg MJ; Kjøller E
    Ugeskr Laeger; 2005 Oct; 167(40):3771-4. PubMed ID: 16221391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purine metabolism in heart failure: oxidant biology and therapeutic indications.
    Bauer JA; Moffatt-Bruce SD; Elton TS; Feldman D
    Congest Heart Fail; 2008; 14(5):283-4. PubMed ID: 18983293
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.